Effects of dermal dexamethasone application on ACTH and both basal and ACTH-stimulated cortisol concentration in normal horses

Journal of Veterinary Pharmacology and Therapeutics

Volumn 32, Issue 4, 2009, Pages 379-387

  Abraham, G ^a   Allersmeier, M ^a   Gottschalk, J ^b   Schusser, G F ^b   Hoppen, H O ^b   Ungemach, F R ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CORTICOTROPIN; CREATINE KINASE; CREATININE; DEXAMETHASONE; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; HYDROCORTISONE; LACTATE DEHYDROGENASE; NEOMYCIN; SORBATE POTASSIUM; TETRACOSACTIDE; UREA; VETERINARY DRUG;

ADOLESCENT; ADRENAL SUPPRESSION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN TEST; DRUG EFFECT; DRUG WITHDRAWAL; EOSINOPHIL; FEEDBACK SYSTEM; FEMALE; HORSE; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LYMPHOCYTE; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; TREATMENT DURATION;

ADMINISTRATION, CUTANEOUS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD CHEMICAL ANALYSIS; DEXAMETHASONE; FEMALE; HEMATOLOGIC TESTS; HORSES; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; RADIOIMMUNOASSAY; SINGLE-BLIND METHOD;

ANIMALIA; EQUIDAE;

EID: 67651250472     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2008.01054.x     Document Type: Article

References (52)

1. Abraham, G., Gottschalk, J. Ungemach, F.R. (2005) Evidence for ototopical glucocorticoid-induced decrease in hypothalamic-pituitary-adrenal axis response and liver function. Endocrinology, 146, 3163 3171.
2. Alexander, S.L., Irvine, C.H., Livesey, J.H. Donald, R.A. (1993) The acute effect of lowering plasma cortisol on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin as revealed by intensive sampling of pituitary venous blood in the normal horse. Endocrinology, 133, 860 866.
3. Bhagwat, A.G. Ross, R.C. (1971) Prednisolone-induced hepatic injury. Ultrastructural and biochemical changes in rabbits. Archives of Pathology, 91, 483 492.
4. Bloemena, E., Weinreich, S. Schellekens, P.T. (1990) The influence of prednisolone on the recirculation of peripheral blood lymphocytes in vivo. Clinical and Experimental Immunology, 80, 460 466.
5. Bornstein, S.R., Engeland, W.C., Ehrhart-Bornstein, M. Herman, J.P. (2008) Dissociation of ACTH and glucocorticoids. Trends in Endocrinology and Metabolism, 19, 175 180.
6. Bousquet-Mélou, A., Formentini, E., Picard-Hagen, N., Delage, L., Laroute, V. Toutain, P.L. (2006) The adrenocorticotropin stimulation test: contribution of a physiologically based model developed in horse for its interpretation in different pathophysiological situations encountered in man. Endocrinology, 147, 4281 4291.
7. Brazzini, B. Pimpinelli, N. (2002) New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use. American Journal of Clinical Dermatology, 3, 47 58.
8. Brus, R. (1999) Effects of high-dose inhaled corticosteroids on plasma cortisol concentrations in healthy adults. Archives of Internal Medicine, 159, 1903 1908.
9. Bugajski, J., Gadek-Michalska, A. Bugajski, A.J. (2001) A single corticosterone pretreatment inhibits the hypothalamic-pituitary-adrenal responses to adrenergic and cholinergic stimulation. Journal of Physiology and Pharmacology, 52, 313 324.
10. Buske-Kirschbaum, A., Jobst, S. Hellhammer, D.H. (1998) Altered reactivity of the hypothalamus-pituitary-adrenal axis in patients with atopic dermatitis: pathologic factor or symptom? Annals of the New York Academy of Sciences, 840, 747 754.
11. Buske-Kirschbaum, A., Geiben, A., Hollig, H., Morschhauser, E. Hellhammer, D. (2002) Altered responsiveness of the hypothalamus-pituitary- adrenal axis and the sympathetic adrenomedullary system to stress in patients with atopic dermatitis. The Journal of Clinical Endocrinology & Metabolism, 87, 4245 4251.
12. Carlson, G.P. (1996) Clinical chemistry tests. In Large Animal Internal Medicine. Ed. Smith, P.S., pp. 441 469. Mosby, St Luis, USA.
13. Chrousos, G.P. (2001) Adrenal suppression versus clinical glucocorticoid deficiency in the premature infant: no simple answers. The Journal of Clinical Endocrinology & Metabolism, 86, 473 474.
14. Clark, D.J. Lipworth, B.J. (1997) Evaluation of corticotropin releasing factor stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients. Chest, 112, 1248 1252.
15. Cohen, N.D. Carter, G.K. (1992) Steroid hepatopathy in a horse with glucocorticoid-induced hyperadrenocorticism. Journal of the American Veterinary Medical Association, 200, 1682 1684.
16. Crowley, S., Hindmarsh, P.C., Honour, J.W. Brook, C.G. (1993) Reproducibility of the cortisol response to stimulation with a low dose of ACTH (1-24): the effect of basal cortisol levels and comparison of low-dose with high-dose secretory dynamics. The Journal of Endocrinology, 136, 167 172.
17. Curtis, C. (1999) Use and abuse of topical dermatological therapy in dogs and cats. Part 2. In Practice, 21, 448 454.
18. Drake, L.A., Dinehart, S.M., Farmer, E.R., Goltz, R.W., Graham, G.F., Hordinsky, M.K., Lewis, C.W., Pariser, D.M., Webster, S.B., Whitaker, D.C., Butler, B., Lowery, B.J., Raimer, S.A., Krafchik, B.R., Olsen, E. Weston, W.L. (1996) Guidelines of care for the use of topical glucocorticosteroids. American Academy of Dermatology, 35, 615 619.
19. Fisher, D.A. (1995) Adverse effects of topical corticosteroid use. The Western Journal of Medicine, 162, 123 126.
20. French, K., Pollitt, C.C. Pass, M.A. (2000) Pharmacokinetics and metabolic effects of triamcinolone acetonide and their possible relationships to glucocorticoid-induced laminitis in horses. Journal of Veterinary Pharmacology and Therapeutics, 23, 287 292.
21. Froin, H.R. (1998) Diagnosis of Equine Cushing's Syndrome by ACTH Measurement. DPC® Technical Report. pp. 1 3. Diagnostic Products Corporation, Los Angeles.
22. Garden, J.M. Freinkel, R.K. (1986) Systemic absorption of topical steroids. Metabolic effects as an index of mild hypercortisolism. Archives of Dermatology, 122, 1007 1010.
23. Hanania, N.A., Chapman, K.R. Kesten, S. (1995) Adverse effects of inhaled corticosteroids. The American Journal of Medicine, 98, 196 208.
24. Hart, K.A., Ferguson, D.C., Heusner, G.L. Barton, M.H. (2007) Synthetic adrenocorticotropic hormone stimulation tests in healthy neonatal foals. Journal of veterinary internal medicine, 21, 314 321.
25. Hengge, U.R., Ruzicka, T., Schwartz, R.A. Cork, M.J. (2006) Adverse effects of topical glucocorticosteroids. Journal of the American Academy of Dermatology, 54, 1 15.
26. Henzen, C., Suter, A., Lerch, E., Urbinelli, R., Schorno, X.H. Briner, V.A. (2000) Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet, 355, 542 545.
27. Johnson, P.J., Slight, S.H., Ganjam, V.K. Kreeger, J.M. (2002) Glucocorticoids and laminitis in the horse. The Veterinary clinics of North America Equine practice, 18, 219 236.
28. Keller-Wood, M.E. Dallman, M.F. (1984) Corticosteroid inhibition of ACTH secretion. Endocrine Reviewes, 5, 1 24.
29. Krasner, A.S. (1999) Glucocorticoid-induced adrenal insufficiency. The Journal of the American Medical Association, 282, 671 676.
30. Levin, C. Maibach, H.I. (2002) Topical corticosteroid-induced adrenocortical insufficiency: clinical implications. American Journal of Clinical Dermatology, 3, 141 147.
31. Lipworth, B.J. (1999) Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Archives of Internal Medicine, 59, 941 955.
32. Livanou, T., Ferriman, D. James, V.H. (1967) Recovery of hypothalamo-pituitary-adrenal function after corticosteroid therapy. Lancet, 2, 856 859.
33. Maibach, H.I., Feldmann, R.J., Milby, T.H. Serat, W.F. (1971) Regional variation in percutaneous penetration in man. Archives of Environmental Health, 23, 208 211.
34. Mills, P.C. Cross, S.E. (2006) Regional differences in the in vitro penetration of hydrocortisone through equine skin. Journal of Veterinary Pharmacology and Therapeutics, 29, 25 30.
35. Nye, E.J., Grice, J.E., Hockings, G.I., Strakosch, C.R., Crosbie, G.V., Walters, M.M. Jackson, R.V. (1999) Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests. The Journal of Clinical Endocrinology and Metabolism, 84, 3648 3655.
36. Patel, L., Clayton, P.E., Addison, G.M., Price, D.A. David, T.J. (1995) Adrenal function following topical steroid treatment in children with atopic dermatitis. British Journal of Dermatology, 132, 950 955.
37. Roberts, S.M., Lavach, J.D., Macy, D.W. Severin, G.A. (1984) Effect of ophthalmic prednisolone acetate on the canine adrenal gland and hepatic function. American Journal of Veterinary Research, 45, 1711 1714.
38. Rush, B.R., Worster, A.A., Flaminio, M.J., Matson, C.J. Hakala, J.E. (1998) Alteration in adrenocortical function in horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. American Journal of Veterinary Research, 59, 1044 1047.
39. Rush, B.R., Raub, E.S., Thomsen, M.M., Davis, E.G., Matson, C.J. Hakala, J.E. (2000) Pulmonary function and adrenal gland suppression with incremental doses of aerosolized beclomethasone dipropionate in horses with recurrent airway obstruction. Journal of the American Veterinary Medical Association, 217, 359 364.
40. Rutgers, H.C., Batt, R.M., Vaillant, C. Riley, J.E. (1995) Subcellular pathologic features of glucocorticoid-induced hepatopathy in dogs. American Journal of Veterinary Research, 56, 898 907.
41. Ryu, S.H., Kim, B.S., Lee, C.W., Yoon, J. Lee, Y.L. (2004) Glucocorticoid-induced laminitis with hepatopathy in a Thoroughbred filly. Journal of Veterinary Science, 5, 271 274.
42. Smith, E.W. (1993) Do we need new and different glucocorticoids? A re-appraisal of the various congeners and potential alternatives. Current Problems in Dermatology, 21, 1 10.
43. Spiess, B.M., Nyikos, S., Stummer, E., Sahin, A. Naegeli, H. (1999) Systemic dexamethasone concentration in horses after continued topical treatment with an ophthalmic preparation of dexamethasone. American Journal of Veterinary Research, 60, 571 576.
44. Streck, W.F. Lockwood, D.H. (1979) Pituitary adrenal recovery following short-term suppression with corticosteroids. The American Journal of Medicine, 66, 910 914.
45. Sulzberger, M.B. Witten, V.H. (1952) The effect of topically applied compound F in selected dermatoses. The Journal of Investigative Dermatology, 19, 101 102.
46. Todd, G.R., Acerini, C.L., Buck, J.J., Murphy, N.P., Ross-Russell, R., Warner, J.T. McCance, D.R. (2002) Acute adrenal crisis in asthmatics treated with high-dose fluticasone propionate. European Respiratory Journal, 19, 1207 1209.
47. Turpeinen, M. (1988) Influence of age and severity of dermatitis on the percutaneous absorption of hydrocortisone in children. British Journal of Dermatology, 118, 517 522. (Pubitemid 18166525)
48. Turpeinen, M. (1989) Adrenocortical response to adrenocorticotropic hormone in relation to duration of topical therapy and percutaneous absorption of hydrocortisone in children with dermatitis. European Journal of Pediatrics, 148, 729 731.
49. Turpeinen, M., Salo, O.P. Leisti, S. (1986) Effect of percutaneous absorption of hydrocortisone on adrenocortical responsiveness in infants with severe skin disease. British Journal of Dermatology, 115, 475 484.
50. Wester, R.C. Maibach, H.I. (1991) In vivo percutaneous penetration. In Dermatotoxicology. Eds Marzulli, F.N. Maibach, H.I., pp. 75 96. Hemisphere Publishing, Washington, DC.
51. Wester, R.C. Maibach, H.I. (1992) percutaneous absorption in diseased skin. In Topical Corticosteroids. Eds Maibach, H.I. Surber, C., pp. 128 141. Karger, Basel.
52. Zenoble, R.D. Kemppainen, R.J. (1987) Adrenocortical suppression by topically applied corticosteroids in healthy dogs. Journal of American Veterinary Medical Association, 191, 685 688.